Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inogen (INGN) Current Deferred Revenue (2016 - 2022)

Inogen (INGN) has disclosed Current Deferred Revenue for 10 consecutive years, with $9.1 million as the latest value for Q3 2022.

  • On a quarterly basis, Current Deferred Revenue rose 8.25% to $9.1 million in Q3 2022 year-over-year; TTM through Sep 2022 was $9.1 million, a 8.25% increase, with the full-year FY2021 number at $8.6 million, up 22.51% from a year prior.
  • Current Deferred Revenue was $9.1 million for Q3 2022 at Inogen, up from $9.0 million in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $17.1 million in Q4 2019 to a low of $3.2 million in Q1 2018.
  • A 5-year average of $7.1 million and a median of $6.8 million in 2020 define the central range for Current Deferred Revenue.
  • Peak YoY movement for Current Deferred Revenue: surged 283.69% in 2019, then tumbled 59.05% in 2020.
  • Inogen's Current Deferred Revenue stood at $4.5 million in 2018, then soared by 283.69% to $17.1 million in 2019, then plummeted by 59.05% to $7.0 million in 2020, then increased by 22.51% to $8.6 million in 2021, then rose by 6.43% to $9.1 million in 2022.
  • Per Business Quant, the three most recent readings for INGN's Current Deferred Revenue are $9.1 million (Q3 2022), $9.0 million (Q2 2022), and $8.7 million (Q1 2022).